Brind.

Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Ghana Swissmedic

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis developed a Bruton's tyrosine kinase inhibitor, with Heinz Wiendl being a professor at the University of Freiburg.Sat 05:09
Ghana
country in West Africa
- Ghana Prisons Service is investigating an attempted poisoning incident while the New Patriotic Party is involved in presidential term speculation.16:21
- The Ghana AIDS Commission is operating within the established Ghanaian legal framework.16:19
Swissmedic
licensing and inspection authority for remedies in Switzerland with headquarters in Bern

Nothing else this week.

Related events

FDA endorsed broader use of a Lilly medicine, and Abogen furnished Novartis with RNA technology.Oct 15

Coverage

Newest first; wire copies grouped

Jul 22mmv.org